The National Health Council (NHC) in a recent post outlines the Food and Drug Administration’s (FDA) Roadmap to Patient-Focused Outcome Measurement in Clinical Trials.
The council also recently hosted a webinar on the FDA’s effort “to help researchers understand and then develop new or adapt existing tools to measure these important outcomes.”
According to the post, the FDA’s roadmap has three steps:
- Understanding the disease or condition;
- Conceptualizing treatment benefit; and
- Selecting/developing the outcome measure.
To read more and to find out how to watch the webinar, click here.